The Future ETF of Early-Stage Investments

4 Nov

By Rory McCann, Marketing Manager & Conference Producer, LSN

KYTO Technology & Life Science is not your typical investment firm. They have a unique model that focuses on the financial investment, mentorship and advising, as well as growth and success of early-stage life science technology and their founding teams. Tom Vogelsong is the Director of Deal Flow and he sat down to discuss what makes KYTO’s outlook and processes different, the unique value they add to their portfolio, and exciting developments in the works.

KYTO is a frequent attendee and valuable asset to the RESI community. Get to know Tom and the team at Digital RESI November 16-18. Partnering is open, but there’s still time to sign up and book meetings! Register today to jumpstart your fundraising.


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: